Business
FDA Approval of LiquiBand® Rapid(TM)
FDA Approval of LiquiBand® Rapid(TM).
About this update from Advanced Medical Solutions Group Plc
[{"type":"text","content":"\n \n \n RNS Number : 5215F\n Advanced Medical Solutions Grp PLC\n 10 March 2020\n \n \n \n \n 10 March 2020\n \n \n \n Advanced Medical Solutions Group plc\n \n \n (\"AMS\" or the \"Group\")\n \n \n \n \n \n FDA Approval of LiquiBand® Rapid™\n \n \n \n \n \n \n \n \n Winsford, UK - 10 March 2020: \n Advanced Medical Solutions Group plc (AIM: AMS), the surgical and advanced woundcare specialist company, today announces that it has received 510(k) approval from the US FDA (\"Food and Drug Administration\") for the Group's LiquiBand® Rapid™ product. \n \n \n \n \n \n The product will be commercialised immediately via one of AMS's main US partners and will upgrade this partner's offering. The Group expects LiquiBand® Rapid™ to enable AMS to regain ground with an improved product. LiquiBand® Rapid™ is a further portfolio extension of AMS's LiquiBand range, with a faster drying time than comparative products and multiple uses in operating room and emergency room settings.\n \n \n \n \n \n Chris Meredith, Chief Executive Officer of AMS, commented:\n \"The approval of LiquiBand® Rapid™ is an important development for our LiquiBand product range\n . Innovation remains a key driver of organic growth for the Group and this approval demonstrates the capabilities of our internal R&D and regulatory teams. The Group remains confident of the growth potential for the LiquiBand® range alongside multiple other woundcare and surgical opportunities including those arising from the acquisitions of Biomatlante and Sealantis.\"\n \n \n \n \n \n \n \n \n - End -\n \n \n \n \n \n \n For further information, please visit \n \n \n www.admedsol.com\n \n \n or contact:\n \n \n \n \n \n \n \n \n \n Advanced Medical Solutions Group plc\n \n \n \n \n Tel: +44 (0) 1606 545508\n \n \n \n \n \n \n Chris Meredith, Chief Executive Officer\n \n \n Eddie Johnson, Chief Financial Officer\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Consilium Strategic Communications\n \n \n \n \n Tel: +44 (0) 20 3709 5700\n \n \n \n \n \n \n Mary-Jane Elliott / Matthew Neal / \n Nicholas Brown / Olivia Manser\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Investec Bank PLC (NOMAD & Broker)\n \n \n \n \n Tel: +44 (0) 20 7597 597...